78 related articles for article (PubMed ID: 16492349)
1. DMPA and BMD.
Parry R; Mansour D
J Fam Plann Reprod Health Care; 2006 Jan; 32(1):53. PubMed ID: 16492349
[No Abstract] [Full Text] [Related]
2. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density and depot medroxyprogesterone acetate.
Albertazzi P; Bottazzi M; Steel SA
Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N
J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
[TBL] [Abstract][Full Text] [Related]
5. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.
Harel Z; Johnson CC; Gold MA; Cromer B; Peterson E; Burkman R; Stager M; Brown R; Bruner A; Coupey S; Hertweck P; Bone H; Wolter K; Nelson A; Marshall S; Bachrach LK
Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
Clark MK; Sowers MR; Nichols S; Levy B
Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
[TBL] [Abstract][Full Text] [Related]
7. Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
Viola AS; Castro S; Marchi NM; Bahamondes MV; Viola CF; Bahamondes L
Contraception; 2011 Aug; 84(2):122-7. PubMed ID: 21757052
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
Cundy T; Ames R; Horne A; Clearwater J; Roberts H; Gamble G; Reid IR
J Clin Endocrinol Metab; 2003 Jan; 88(1):78-81. PubMed ID: 12519833
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
[TBL] [Abstract][Full Text] [Related]
10. Injectable contraception.
Roy G
Semin Reprod Med; 2010 Mar; 28(2):126-32. PubMed ID: 20352562
[TBL] [Abstract][Full Text] [Related]
11. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age.
Gai L; Zhang J; Zhang H; Gai P; Zhou L; Liu Y
Contraception; 2011 Mar; 83(3):218-22. PubMed ID: 21310282
[TBL] [Abstract][Full Text] [Related]
12. DMPA and bone density.
BMJ; 1991 Aug; 303(6800):467-8. PubMed ID: 1833007
[No Abstract] [Full Text] [Related]
13. In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents.
Cromer B
J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183-7. PubMed ID: 15970253
[No Abstract] [Full Text] [Related]
14. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
[TBL] [Abstract][Full Text] [Related]
15. Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning.
Omar H; Kives S
J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183. PubMed ID: 15970252
[No Abstract] [Full Text] [Related]
16. Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: adolescents who lost 5% or more from baseline vs. those who lost less than 5%.
Harel Z; Wolter K; Gold MA; Cromer B; Stager M; Johnson CC; Brown R; Bruner A; Coupey S; Hertweck P; Bone H; Burkman R; Nelson A; Marshall S; Bachrach LK
Contraception; 2010 Dec; 82(6):503-12. PubMed ID: 21074012
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density and DMPA.
Westhoff C
J Reprod Med; 2002 Sep; 47(9 Suppl):795-9. PubMed ID: 12380409
[TBL] [Abstract][Full Text] [Related]
19. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
Cromer BA; Stager M; Bonny A; Lazebnik R; Rome E; Ziegler J; Debanne SM
J Adolesc Health; 2004 Dec; 35(6):434-41. PubMed ID: 15581522
[TBL] [Abstract][Full Text] [Related]
20. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
Shaarawy M; El-Mallah SY; Seoudi S; Hassan M; Mohsen IA
Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
